Skip to main content
HLB bioStep Co.,Ltd. logo

HLB bioStep Co.,Ltd. — Investor Relations & Filings

Ticker · 278650 ISIN · KR7278650007 KO Professional, scientific and technical activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2020-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 278650

About HLB bioStep Co.,Ltd.

http://hlbbiostep.com/en/

HLB bioStep Co.,Ltd. is a non-clinical Contract Research Organization (CRO) that provides a range of testing services to pharmaceutical companies and bio ventures. The company's core services support new drug development and include efficacy testing, pharmacokinetic/toxicokinetic (PK/TK) studies, and toxicology evaluations. A key area of specialization is veterinary medicine; HLB bioStep is an institution approved to conduct non-clinical tests and clinical trials for veterinary drugs. It also offers consulting services for regulatory approval procedures. The company utilizes various platform technologies, such as cell-enzyme-based screening and xenograft assays, and provides a comprehensive 'One-Stop Service' that leverages its experience in building laboratory facilities.

Recent filings

Filing Released Lang Actions
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'KNOTUS CO., LTD.' covering the period from January 1, 2020, to June 30, 2020. It contains detailed financial information, business descriptions, management discussions, and corporate governance data, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (연결재무제표 기준 영업(잠정)실적) for the company 'Notus' for the second quarter of 2020. It provides key financial highlights such as revenue, operating profit, and net income in a table format. It is a direct announcement of financial results rather than a full report or a mere notification of a report's publication. Therefore, it fits the definition of an Earnings Release (ER). Q2 2020
2020-08-06 Korean
[기재정정]주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Notus) regarding the exercise of stock options (주식매수선택권행사). It details the number of shares exercised, the exercise price, and the impact on the company's capital structure (issuance of new shares). This falls under the category of share issuance or capital changes resulting from stock option exercises, which is best classified as SHA (Share Issue/Capital Change).
2020-06-22 Korean
조회공시요구(현저한시황변동)에대한답변(중요정보없음)
Regulatory Filings Classification · 95% confidence The document is a formal response to a Korea Exchange (KRX) inquiry regarding significant market fluctuations (unusual stock price/volume activity). It explicitly states that there is no material non-public information to disclose. This is a standard regulatory disclosure required by stock exchange rules, which fits the 'Regulatory Filings' (RNS) category as it does not fall into specific financial reporting or corporate action categories.
2020-06-19 Korean
조회공시요구(현저한시황변동)
Regulatory Filings Classification · 95% confidence The document is a formal request from a regulatory body (exchange) to a company (Noteus) regarding 'significant market fluctuations' (현저한 시황변동). It asks the company to disclose whether there are any undisclosed material events. This is a standard regulatory inquiry/announcement and does not fit into specific financial reporting categories like 10-K or ER, making it a regulatory filing.
2020-06-18 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Agreement' (신탁계약등에의한취득상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the company's (Knotus Co., Ltd.) purchase of its own shares through a trust contract with Samsung Securities. This type of filing, which reports the company's buyback activity, falls under the category of 'Transaction in Own Shares' (POS).
2020-06-16 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.